Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Satavaptan for prevention of recurrent ascites in cirrhosis
2006-000134-12Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cirrhosis and ascites comparing Satavaptan plus concomitant diuretics with Placebo plus concomitant diuretics (2 arms). Primary endpoint: Number and time to recurrence of therapeutic paracenteses during first 12 weeks. Started Mar 2006; status: terminated.
02
Drugs
satavaptan
03
Conditions
Cirrhosisascites
Beyond the preview
Go deeper on 2006-000134-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000134-12.